Neoreviews
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz:
 Vol. 8 No. 2, February 2007
Right arrow E-Letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-Letters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wong, R. J.
Right arrow Articles by Vreman, H. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wong, R. J.
Right arrow Articles by Vreman, H. J.

NeoReviews Vol.8 No.2 2007 e58
© 2007 American Academy of Pediatrics

Neonatal Jaundice

Bilirubin Physiology and Clinical Chemistry

Ronald J. Wong, MD*
David K. Stevenson, MD*
Charles E. Ahlfors, CE*
Hendrik J. Vreman, MD*

* Department of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University School of Medicine, Stanford, Calif

Cleavage of the alpha-methene bridge of heme by membrane-bound heme oxygenase yields equimolar amounts of biliverdin, carbon monoxide, and reduced iron. Biliverdin is catalyzed by biliverdin reductase to bilirubin. The process occurs in all nucleated cells except mature anucleated red blood cells. Neonates in whom bilirubin production is increased tend to have higher bilirubin concentrations, and excessive bilirubin production or impairment of elimination causes dramatic deviations from the hour-specific nomogram that can be seen as "jumping" percentile tracks early in the postnatal period or later in the first week after birth. After formation, bilirubin diffuses into the circulation. In the absence of conjugates, the total bilirubin concentration in plasma is the sum of bilirubin bound to albumin plus a minimal amount of free bilirubin. Bilirubin is excreted more slowly in newborns than in adults. Although no clinical tests can measure bilirubin uptake and conjugation by the liver, an elevated hour-specific total bilirubin value when bilirubin production is normal or decreasing is a sign of impaired or abnormally delayed bilirubin excretion. The accuracy and precision of clinical laboratory total bilirubin measurements are a concern, and studies are underway to assess whether measurements of free bilirubin, the bilirubin-binding constant, the bilirubin:albumin ratio, or albumin binding capacity might improve the ability to identify infants at greater risk for bilirubin-induced neuroinjury rather than simply those at greater risk for having a higher bilirubin concentration.






HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Academy of Pediatrics.